Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Spelman

Showing results (171-180 of 266) with videos related to

Pageof 27
Sort By:
AIDS (London, England)|March 26, 2013
Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndromeChristina C Chang, Afton A Dorasamy, Bernadett I Gosnell, et al.
BMJ Open|June 18, 2025
Evaluation of a telehealth service to support breast cancer prevention medication uptake: a protocol of a mixed methods studyKatrina Louise West, Tim Spelman, Wanda Cui, et al.
The Journal of Infectious Diseases|September 4, 2010
Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocationReena Rajasuriar, David Booth, Ajantha Solomon, et al.
The Journal of Infectious Diseases|March 4, 2014
Lipopolysaccharide, immune activation, and liver abnormalities in HIV/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapyMegan Crane, Anchalee Avihingsanon, Reena Rajasuriar, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 26, 2025
QuantiFERON-CMV Monitoring Post-Allogeneic Hematopoietic Stem Cell Transplantation Is Dynamic and Predictive of Immediate Cytomegalovirus OutcomesBeatrice Z Sim, Chhay Lim, Siobhan Mineely, et al.
BMC Cancer|March 24, 2025
Rehabilitation after bone marrow transplant compared with usual care to improve patient outcomes (REBOOT): protocol for a randomised controlled trialLinda Denehy, Shaza Abo, Christopher Swain, et al.
The Lancet Regional Health. Western Pacific|September 25, 2024
Invasive fungal disease and antifungal prophylaxis in children with acute leukaemia: a multicentre retrospective Australian cohort studyDaniel K Yeoh, Christopher C Blyth, Julia E Clark, et al.
Health & Justice|April 28, 2026
C no more: a prospective single-arm study to evaluate the effectiveness of a nurse and peer-led mobile model of hepatitis C testing and treatment at community corrections officesSamara Griffin, Timothy Papaluca, Jacinta A Holmes, et al.
BMJ Open|May 17, 2024
Minimising Adverse Drug Reactions and Verifying Economic Legitimacy-Pharmacogenomics Implementation in Children (MARVEL- PIC): protocol for a national randomised controlled trial of pharmacogenomics implementationRachel Conyers, Andreas Halman, Claire Moore, et al.
The Journal of Infectious Diseases|June 15, 2013
Cryptococcosis-IRIS is associated with lower cryptococcus-specific IFN-γ responses before antiretroviral therapy but not higher T-cell responses during therapyChristina C Chang, Andrew Lim, Saleha Omarjee, et al.
Pageof 27

Showing results (171-180 of 266) with videos related to

Sort By:
Pageof 27
AIDS (London, England)|March 26, 2013
Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndromeChristina C Chang, Afton A Dorasamy, Bernadett I Gosnell, et al.
BMJ Open|June 18, 2025
Evaluation of a telehealth service to support breast cancer prevention medication uptake: a protocol of a mixed methods studyKatrina Louise West, Tim Spelman, Wanda Cui, et al.
The Journal of Infectious Diseases|September 4, 2010
Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocationReena Rajasuriar, David Booth, Ajantha Solomon, et al.
The Journal of Infectious Diseases|March 4, 2014
Lipopolysaccharide, immune activation, and liver abnormalities in HIV/hepatitis B virus (HBV)-coinfected individuals receiving HBV-active combination antiretroviral therapyMegan Crane, Anchalee Avihingsanon, Reena Rajasuriar, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 26, 2025
QuantiFERON-CMV Monitoring Post-Allogeneic Hematopoietic Stem Cell Transplantation Is Dynamic and Predictive of Immediate Cytomegalovirus OutcomesBeatrice Z Sim, Chhay Lim, Siobhan Mineely, et al.
BMC Cancer|March 24, 2025
Rehabilitation after bone marrow transplant compared with usual care to improve patient outcomes (REBOOT): protocol for a randomised controlled trialLinda Denehy, Shaza Abo, Christopher Swain, et al.
The Lancet Regional Health. Western Pacific|September 25, 2024
Invasive fungal disease and antifungal prophylaxis in children with acute leukaemia: a multicentre retrospective Australian cohort studyDaniel K Yeoh, Christopher C Blyth, Julia E Clark, et al.
Health & Justice|April 28, 2026
C no more: a prospective single-arm study to evaluate the effectiveness of a nurse and peer-led mobile model of hepatitis C testing and treatment at community corrections officesSamara Griffin, Timothy Papaluca, Jacinta A Holmes, et al.
BMJ Open|May 17, 2024
Minimising Adverse Drug Reactions and Verifying Economic Legitimacy-Pharmacogenomics Implementation in Children (MARVEL- PIC): protocol for a national randomised controlled trial of pharmacogenomics implementationRachel Conyers, Andreas Halman, Claire Moore, et al.
The Journal of Infectious Diseases|June 15, 2013
Cryptococcosis-IRIS is associated with lower cryptococcus-specific IFN-γ responses before antiretroviral therapy but not higher T-cell responses during therapyChristina C Chang, Andrew Lim, Saleha Omarjee, et al.
Pageof 27